Sticky Patch Defibrillator; State Telehealth Laws and BP Meds; Ketones and HFpEF?

The Jewel patch-wearable cardioverter-defibrillator delivered successful shocks for protection from sudden cardiac arrest, and people were highly compliant to wearing the water-resistant device. (Journal of the American College of Cardiology)

People with long QT syndrome could perform vigorous exercise without experiencing excess cardiac events, according to observational data. (Circulation)

A Brooklyn bus driver reportedly had a cardiac episode while on the job, which caused him to crash into a Burger King. (ABC7)

In patients with persistent atrial fibrillation, additional mapping-guided ablation of focal activation sites did not improve clinical outcomes compared with pulmonary vein isolation alone, a small trial found. (Circulation: Arrhythmia and Electrophysiology)

Dapagliflozin (Farxiga) may confer benefits in heart failure with preserved ejection fraction (HFpEF) via its effects on dynamic right ventricular-pulmonary vascular coupling associated with pulmonary capillary wedge pressure reduction. (JAMA Cardiology)

A ketone supplement could help heart metabolism in HFpEF, according to preclinical research highlighted by the American Heart Association.

State telehealth payment (not coverage) parity laws were associated with greater blood pressure medication adherence. (Circulation: Cardiovascular Quality and Outcomes)

The OPTiMISE trial’s antihypertensive deprescribing intervention continued to be safe for some elderly people with controlled blood pressure. (Lancet Healthy Longevity)

The first-in-human implantation of the BiVACOR Total Artificial Heart was successful as a bridge to transplant, according to the Texas Heart Institute.

A study validated the prognostic value of looser criteria for post-capillary pulmonary hypertension in heart failure. (European Heart Journal)

The Watchman FLX continued to show good safety for left atrial appendage occlusion in a postapproval registry. (Circulation: Cardiovascular Interventions)

Can automated 3D echocardiographic software analysis predict mitral annular dimensions and left ventricular outflow tract obstruction risk before transcatheter mitral valve replacement? (JACC: Cardiovascular Imaging)

The CETP inhibitor obicetrapib reduced LDL cholesterol by 41.5% at 1 year in the phase III BROOKLYN trial in heterozygous familial hypercholesterolemia, NewAmsterdam Pharma announced.

The benefits of endovascular thrombectomy for strokes with large infarct were sustained through 1 year in the TENSION trial. (Lancet Neurology)

Early surgery for acute active infective endocarditis appeared feasible soon after a stroke, as people did not suffer more stroke complications. (Annals of Thoracic Surgery)

Daily low-dose aspirin did not halt the progression of age-related hearing loss in ASPREE. (JAMA Network Open)

Please enable JavaScript to view the

comments powered by Disqus.